这是一篇来自已证抗体库的有关人类 tissue factor pathway inhibitor的综述，是根据2篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合tissue factor pathway inhibitor 抗体。
tissue factor pathway inhibitor 同义词: EPI; LACI; TFI; TFPI1; tissue factor pathway inhibitor; anti-convertin; extrinsic pathway inhibitor; tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)

圣克鲁斯生物技术
小鼠 单克隆（G-5）
  • 免疫印迹; 小鼠; 1:200; 图 2h
圣克鲁斯生物技术 tissue factor pathway inhibitor抗体（Santa Cruz, sc-365920)被用于被用于免疫印迹在小鼠样品上浓度为1:200 (图 2h). J Cell Sci (2018) ncbi
艾博抗（上海）贸易有限公司
兔 多克隆
  • 免疫组化; 人类; 1:200; 图 4b
  • 免疫印迹; 人类; 1:500; 图 1b
艾博抗（上海）贸易有限公司 tissue factor pathway inhibitor抗体（Abcam, ab180619)被用于被用于免疫组化在人类样品上浓度为1:200 (图 4b) 和 被用于免疫印迹在人类样品上浓度为1:500 (图 1b). Mol Vis (2016) ncbi
文章列表
  1. Xu S, Zhou Z, Li H, Liu Z, Pan X, Wang F, et al. BMSCs ameliorate septic coagulopathy by suppressing inflammation in cecal ligation and puncture-induced sepsis. J Cell Sci. 2018;131: pubmed 出版商
  2. Abu El Asrar A, Siddiquei M, Nawaz M, De Hertogh G, Mohammad G, Alam K, et al. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy. Mol Vis. 2016;22:424-35 pubmed